0

Unconditional Gifted Savings for Poverty

UI
D
Overseen ByDean-SP2
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Unconditional Gifted Savings for Poverty is an effective treatment?

The available research does not provide any data specifically supporting the effectiveness of Unconditional Gifted Savings for Poverty. The studies mentioned focus on other programs and treatments, such as intensive care management for high-cost patients and complex care programs for Medicaid patients, which show cost reductions and improved outcomes. However, these findings do not directly relate to Unconditional Gifted Savings for Poverty.12345

What safety data exists for Unconditional Gifted Savings for Poverty?

The provided research does not contain any safety data related to Unconditional Gifted Savings for Poverty or similar programs. The studies focus on pediatric adverse events, emergency department safety, medication safety, anesthesia-related events, and hospital safety programs, none of which are relevant to the safety of financial assistance programs like Unconditional Gifted Savings.678910

Is the treatment 'Unconditional Gifted Savings for Poverty' a promising treatment?

Yes, the treatment is promising because unconditional cash transfers can help reduce poverty and improve health outcomes by providing financial support without any conditions.1112131415

What is the purpose of this trial?

The goal of this randomized control trial is to test the impacts of an unconditional Gifted Savings account of $2,000 of assets ($100 United States Dollars available upon enrollment; $500 United States Dollars available for emergency use each year for two years) on adults with household incomes of three times the Federal Poverty Level or less in Yellow Springs, Ohio.

Research Team

SW

Stacia West, PhD

Principal Investigator

University of Pennsylvania

Eligibility Criteria

This trial is for adults living in Yellow Springs, Ohio with a household income at or below three times the Federal Poverty Level. Participants must be at least 18 years old. Those not residing in Yellow Springs, under 18, or earning above the income limit cannot join.

Inclusion Criteria

Resident of Yellow Springs, Ohio
Annual household income of three times the Federal Poverty Level or less

Exclusion Criteria

Annual household income of more than three times the Federal Poverty Level
Not a resident of Yellow Springs, Ohio

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Enrollment

Participants register on the Gifted Savings website to claim their account

1 week
1 visit (virtual)

Treatment

Participants receive a Gifted Savings account with $2,000 of assets

24 months
Annual check-ins

Follow-up

Participants complete follow-up surveys to assess various financial and psychological outcomes

12 months
6 visits (virtual)

Treatment Details

Interventions

  • Gifted Savings
Trial Overview The study is examining if giving an unconditional Gifted Savings account with $2,000 affects poverty levels. Upon joining, participants get $100 and can use $500 each year for emergencies over two years.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Gifted SavingsExperimental Treatment1 Intervention
Participants in the treatment group will receive an unconditional Gifted Savings account with $2,000 of assets ($100 USD available upon enrollment; $500 USD available for emergency use each year for two years).
Group II: No Gifted SavingsActive Control1 Intervention
Participants in the control group will not receive a Gifted Savings account.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Universal Gifted Savings

Collaborator

Trials
1

Findings from Research

The implementation of an outcomes-management program for gynecologic oncology procedures significantly reduced the median hospital stay from 6 days to 4 days, indicating improved efficiency in patient care.
The program also led to substantial cost reductions, including a 74% decrease in laboratory costs and a 20% decrease in total hospital costs, while maintaining high patient satisfaction and no readmissions for complications.
An outcomes management program in gynecologic oncology.Morris, M., Levenback, C., Burke, TW., et al.[2022]
The Care One program, which provides intensive care management for high-cost, medically complex patients, was associated with a significant reduction in billed charges, averaging $92,227 per patient, indicating its potential effectiveness in cost containment.
Using a difference-in-difference model, the program showed a more conservative reduction of $44,504 per patient compared to a control group, highlighting the program's ability to lower costs while managing complex health needs.
The Economic Impact of Intensive Care Management for High-Cost Medically Complex Patients: An Evaluation of New Mexico's Care One Program.Horn, BP., Crandall, C., Moffett, M., et al.[2017]
In a study of 867 long-stay nursing facility residents, it was found that symptoms like falls, trauma, or fractures were more commonly treated in the emergency department (ED) rather than resulting in hospital admissions, indicating a potential area for reducing unnecessary hospital transfers.
Residents with cognitive impairment and respiratory complaints were more likely to be admitted to the hospital, while those presenting with hematological issues, pain, or falls were less likely to be hospitalized, suggesting that understanding these characteristics can help optimize transfer protocols and reduce hospitalizations.
Long-Stay Nursing Facility Resident Transfers: Who Gets Admitted to the Hospital?Unroe, KT., Caterino, JM., Stump, TE., et al.[2021]

References

An outcomes management program in gynecologic oncology. [2022]
The Economic Impact of Intensive Care Management for High-Cost Medically Complex Patients: An Evaluation of New Mexico's Care One Program. [2017]
Long-Stay Nursing Facility Resident Transfers: Who Gets Admitted to the Hospital? [2021]
Facility and resident characteristics associated with variation in nursing home transfers: evidence from the OPTIMISTIC demonstration project. [2021]
Building a Medicaid Ambulatory Complex Care Program Within an Urban Medical Home. [2019]
Pediatric Adverse Event Rates Associated With Inexperience in Teaching Hospitals: A Multilevel Analysis. [2019]
How safe are paediatric emergency departments? A national prospective cohort study. [2022]
Effects of a pharmacist-led pediatrics medication safety team on medication-error reporting. [2022]
Outcomes from wake up safe, the pediatric anesthesia quality improvement initiative. [2021]
Reducing Serious Safety Events and Priority Hospital-Acquired Conditions in a Pediatric Hospital with the Implementation of a Patient Safety Program. [2019]
Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries. [2022]
Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries. [2023]
13.United Statespubmed.ncbi.nlm.nih.gov
A difference-in-differences approach to estimate the effect of income-supplementation on food insecurity. [2014]
Unconditional cash transfers for assistance in humanitarian disasters: effect on use of health services and health outcomes in low- and middle-income countries. [2022]
An assessment of the Francois-Xavier Bagnoud poverty alleviation program in Rwanda and Uganda. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security